Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Mental Status and Dementia Tests 3Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Trastuzumab 1Surveys and Questionnaires 1Paclitaxel 1Folfox protocol 1Fluorodeoxyglucose F18 1Doxorubicin 1Docetaxel 1Diffusion Tensor Imaging 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Aromatase Inhibitors 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neurotoxicity Syndromes × Folfox protocol × Clear all
NCT05494320 2022-08-09

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Ain Shams University

Unknown
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡